Target intelligence / Profile preview

Receptor-operated calcium channel (ROCC)

Target
ROCC
Molecular classification
Ion channel, Receptor, Transient receptor potential (TRP) channel family, Cation channel
01

Overview

Receptor-operated calcium channels are a class of ion channels permeable to calcium ions, activated in response to agonist binding at G-protein-coupled receptors or other cell surface receptors, independent of membrane depolarization. They often consist of transient receptor potential canonical (TRPC) channel subunits, and are found in various tissues, especially smooth muscle and vasculature, where they mediate calcium influx in response to stimuli like neurotransmitters and hormones. ROCCs regulate key functions including smooth muscle contraction, vascular tone, and cell proliferation, and are implicated in diseases such as hypertension, vascular remodeling, and some cancers. Currently, there are no highly specific drugs targeting ROCCs in clinical use, though experimental compounds exist. Their close relationship with store-operated calcium channels (SOCCs) and molecular overlap with other TRP channels present challenges for therapeutic targeting.

Other names
ROCCReceptor-operated calcium-permeable channelReceptor-operated cation channelReceptor-activated calcium channel
02

Mechanism of action

Inhibition or modulation of receptor-operated calcium channels diminishes receptor-induced calcium influx, which can reduce smooth muscle contraction, cell proliferation, or other downstream signaling. Often acts through blockade of TRP channels (primarily TRPC subtypes) or through modulation of the PI(4,5)P2/phospholipase C pathway.

03

Biological functions

Signal transductionCalcium influx regulationSmooth muscle contractionVascular tone regulationCell proliferation
04

Disease associations

Cardiovascular diseaseHypertensionVascular remodelingInflammationCancer
05

Safety considerations

Off-target effects due to overlap with other channel types (e.g., store-operated and voltage-gated calcium channels)Difficulty in developing selective modulators for ROCCs, as they share subunits with other ion channelsPotential impact on vascular tone, blood pressure, and cardiac function if blocked systemically
06

Interacting drugs

No widely used, ROCC-specific drugs with clinical relevance; some research compounds affecting TRPC (transient receptor potential canonical) channels (e.g., SKF-96365, 2-APB)

2 more in the full profile.

07

Biomarkers

No established clinical biomarkers specific for ROCC activity

Beyond the preview

Go deeper on Receptor-operated calcium channel (ROCC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Receptor-operated calcium channel (ROCC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call